###begin article-title 0
Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 77 86 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
To investigate the possible association between tumor necrosis factor alpha (TNF-alpha)-308 G/A polymorphism and pseudoexfoliation (PEX) glaucoma.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 173 182 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 115 127 <span type="species:ncbi:9606">participants</span>
One hundred and ten Turkish PEX glaucoma patients and 110 healthy control subjects were enrolled in the study. All participants underwent a complete ophthalmic examination. TNF-alpha-308 was genotyped by polymerase chain reaction and restriction endonuclease analysis.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
We found a high prevalence of the G/G genotype in PEX glaucoma patients (OR=2.88, 95% CI 1.15-7.20). The A polymorphic allele frequency was 3.2% in patients with PEX compared with 8.2% in controls (p=0.023).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 25 34 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
Our results suggest that TNF-alpha-308 G/A genotype is not associated with PEX glaucoma. The -308G/A variant may be a possible protective factor against PEX.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 185 186 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 275 276 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 505 506 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 836 837 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 966 967 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 974 983 962 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1132 1133 1112 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1183 1192 1163 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1252 1253 1224 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1315 1324 1287 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1350 1358 <span type="species:ncbi:9606">patients</span>
Glaucoma is characterized by a progressive loss of retinal ganglion cells. A previous study suggests that tumor necrosis factor alpha (TNF-alpha) may contribute to the disease process [1]. Pseudoexfoliation (PEX) is the most common identifiable cause of open-angle glaucoma [2]. The pathogenesis of PEX is still uncertain. PEX is associated with the excessive synthesis and deposition of an abnormal elastic microfibrillar material in all tissues of the anterior segment of the eyes and systemic tissues [3]. Excessive production and accumulation of abnormal matrix components may be due to increased de novo synthesis, decreased turnover of matrix components, or both. The extracellular matrix turnover is mediated by matrix metalloproteinases (MMPs). The tissue inhibitors of metalloproteinases (TIMPs) regulate the activity of MMPs [4]. Both MMP and TIMP expression are affected by TNF-alpha. An increased level of TNF-alpha might induce extra MMPs and/or TIMPs [5]. The TNF-alpha gene polymorphisms at position -308 and -238 are the best characterized polymorphisms and have been demonstrated to influence TNF-alpha expression [6].The G to A substitution at the -308 position of TNF-alpha (TNF2 allele) also results in higher TNF-alpha production [7]. In this study, we aimed to investigate the distribution of TNF-alpha-308 gene polymorphism in patients with PEX glaucoma.
###end p 11
###begin title 12
Methods
###end title 12
###begin p 13
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
###xml 317 323 <span type="species:ncbi:9103">Turkey</span>
###xml 1403 1411 <span type="species:ncbi:9606">patients</span>
###xml 1447 1455 <span type="species:ncbi:9606">Patients</span>
This case-control study included 110 patients with unilateral or bilateral PEX glaucoma, and 110 control subjects. The control group and PEX patients were selected from the General Ophthalmology Polyclinic and Glaucoma section, respectively (Department of Ophthalmology, Ankara University School of Medicine, Ankara, Turkey). On ophthalmologic examination, the anterior and posterior segments of all the cases were evaluated, and intraocular pressures (IOP) were measured with Goldmann applanation tonometry. The corneal endothelium, iris, and iris margins were evaluated for pseudoexfoliative material before dilation, and after dilation, the anterior lens surface was examined. To evaluate the angle for pseudoexfoliative material and increased pigmentation, we used gonioprisms. Criteria for inclusion in normal subjects were IOP less than 22 mmHg, normal visual fields, no evidence of glaucomatous changes in optic disc, and no history of glaucoma or ocular hypertension in first-degree relatives. These controls had no pseudoexfoliative material at the anterior lens capsule or pupillary margin. Unilateral or bilateral PEX glaucoma was diagnosed by the presence of PEX in the anterior segment, elevated intraocular pressure (>21mmHg), typical glaucomatous optic nerve changes (notching, thinner neuroretinal rim, and increased cup-to-disc ratio), and glaucomatous visual field defects. All of the patients and control subjects were Turkish. Patients and controls were informed of the experiment including a detailed explanation of all the procedures and gave their consent. The study was conducted in accordance with the principles of the Declaration of Helsinki.
###end p 13
###begin title 14
###xml 0 9 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
TNF-alpha-308 polymorphism
###end title 14
###begin p 15
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 733 734 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 41 53 <span type="species:ncbi:9606">participants</span>
Venous blood samples were taken from all participants. Genomic DNA was isolated from peripheral blood by conventional phenol-chloroform method. The polymerase chain reaction (PCR) method was described in previous studies [8,9]. A 194 bp promoter region containing the polymorphism site was amplified [10] by using primers 5'-AAT GGA AAT AGG TTT TGA GGG T*CA T-3' and 5'-TCT CGG TTT CTT CTC CAT CGC-3' in which T* was not in the genomic DNA sequence and was introduced to create a potential BspHI site (New England Biolabs Inc., Ipswich, MA). PCR was performed in a total volume of 50 mul containing 5 mul of DNA template, 1 U Taq polymerase (Fermentas, Vilnius, Lithuania) in appropriate 10X buffer, 200 muM of dNTP each, 1.5 mM MgCl2, and 25 pM of each of the primers. Cycling conditions were as follows: initial denaturation at 94 degreesC for 5 min followed by 35 cycles at 94 degreesC denaturation for 30 s, 55 degreesC annealing for 30 s, and 72 degreesC extension for 30 s. A final extension was performed at 72 degreesC for 7 min. The product was electrophoresed in a 1% (wt/vol) agarose gel, and bands were visualized under ultraviolet (UV) after ethidium bromide staining.
###end p 15
###begin p 16
To determine the A allele at position -308, 12.5 mul of the PCR product was digested overnight with 10 U of the enzyme, BspHI, at 37 degreesC and electrophoresed in a 2.5% (wt/vol) agarose gel. This digestion results in an uncut 194 bp fragment when G is present at -308 position and in two fragments of 169 bp and 25 bp when A (TNF2) is present.
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
###xml 43 44 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 131 132 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 348 350 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 351 353 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 462 463 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Nominal variables were evaluated by the chi2 test, and the odds ratio was calculated. Age was compared between groups by Student's t-test. Allele frequencies were determined by gene counting. To assess the agreement between genotypes observed and those predicted by the Hardy-Weinberg equilibrium, the likelihood ratio test (G statistic) was used [11,12]. A sample size of 220 achieves 80% power to detect an effect size (W) of 0.19 using 1degrees of freedom chi2 test with a significance level (alpha) of 0.05. A p value less than 0.05 was considered statistically significant.
###end p 18
###begin title 19
Results
###end title 19
###begin p 20
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 173 182 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 359 368 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 604 611 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
There were no statistically significant differences between the ages and sex of the patients and controls (p=0.144, p=0.589, respectively; Table 1). The distribution of the TNF-alpha G/A polymorphism was in accordance with the Hardy-Weinberg equilibrium in the PEX patients with glaucoma and the controls (p=0.657, p=0.218, respectively). The distribution of TNF-alpha G/A polymorphism between PEX glaucoma patients and controls was significantly different from each other (p=0.019). The frequency of the GG genotype in the PEX glaucoma group was higher than that of controls (OR=2.88, 95% CI 1.15-7.20; Table 2). The frequencies of the A and G alleles were significantly different between the groups (p=0.023; A=7 (3.2%), G=213 (96.8%) and A=18 (8.2%), G=202 (91.8%) for PEX glaucoma and control groups, respectively).
###end p 20
###begin title 21
###xml 31 43 <span type="species:ncbi:9606">participants</span>
Demographic characteristics of participants.
###end title 21
###begin title 22
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of the patients with PEX glaucoma and the controls.
###end title 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
Progressive accumulation of PEX material in the juxtacanalicular tissue causes an increase in intraocular pressure in PEX syndrome [13,14]. The pathogenesis of an aberrant matrix process is still unknown. Recent studies showed that lysil oxidase-like 1 gene polymorphisms were highly associated with PEX [15-17].
###end p 24
###begin p 25
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 397 398 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 527 536 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 577 578 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 662 671 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 727 736 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 808 817 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 843 845 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
MMPs and TIMPs can play a role in the development of an abnormal extracellular matrix characteristic of PEX syndrome/glaucoma and primary open-angle glaucoma [13,14]. MMPs belongs to the endopeptidases family, and they contribute to trabecular extracellular matrix degradation [18,19]. TIMPs regulate the activity of the MMPs. An increased level of TNF-alpha might induce extra MMPs and/or TIMPs [5]. The functional polymorphisms in the promoter region affect plasma TNF-alpha levels. A G to A polymorphism at position -308 of TNF-alpha is associated with elevated TNF levels [7]. It is possible that another single nucleotide polymorphism (SNP) might be within TNF-alpha that is more relevant to TNF-alpha production than the TNF-alpha-308 A allele. However, a neat association between TNF-alpha levels and TNF-alpha-308 polymorphism exists [20]. Therefore, other polymorphisms in this gene could have less of an effect on TNF-alpha levels.
###end p 25
###begin p 26
###xml 12 14 12 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 54 63 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 182 191 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 264 266 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 337 346 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 472 474 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 537 546 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
Lin et al. [21] evaluated the association between the TNF-alpha-308 polymorphism and primary open-angle glaucoma (POAG) in Chinese patients. They determined that the distribution of TNF-alpha-308 G/A was significantly higher in the POAG patients. Mossbock et al. [22] concluded that allelic frequencies and genotype distributions of the TNF-alpha-308G/A polymorphisms did not significantly differ between Caucasian patients with POAG and control subjects. Funayama et al [23]. did not find significant difference in the frequency of the TNF-alpha-308 G/A genotype between Japanese patients with glaucoma (POAG or normal pressure glaucoma) and healthy subjects.
###end p 26
###begin p 27
###xml 55 64 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 498 507 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 566 575 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 667 668 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 669 670 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 671 673 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 868 877 856 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1303 1305 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1334 1336 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 1625 1627 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 1650 1652 1622 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1773 1775 1745 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
###xml 289 297 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 635 641 <span type="species:ncbi:9103">Turkey</span>
In this study, we investigated the distribution of the TNF-alpha-308 polymorphism in Turkish PEX glaucoma patients. TNF G/A genotype was also found to be lower in our PEX glaucoma patients than in control subjects, we detected a high prevalence of the G/G genotype in Turkish PEX glaucoma patients. However, our main hypothesis was to demonstrate the higher frequency of the GA genotype in PEX glaucoma patients. To our knowledge, this is the first study that evaluated the association between the TNF-alpha polymorphism and PEX glaucoma. It is interesting that the TNF-alpha-308 A allele frequency is similar to previous studies from Turkey in different age groups [8,9,24]. Further, Turkish population is an admixture of several Caucasian individuals who have emigrated from different parts of the world, but there is no admixture with the Japanese and Chinese. The TNF-alpha-308 G/A polymorphism has been studied in association with different complex diseases. Although increased TNF-alpha expression is linked to several diseases, some studies similar to ours have reported opposite results. The exact etiology of psoriasis is still unclear but the increased levels and activity of proinflammatory cytokines, such as tumor necrosis factor (TNF)-alpha were suggested in the development of psoriasis [25]. However, Chunying et al. [26] performed a meta-analysis, and they found there was a protective effect for the -308G/A variant genotypes compared with the wild type homozygous genotypes. TNF-alpha produces hypertriglyceridemia mediated by decreased lipolysis, and increased very density lipoproteins (VLDL) secretion [27]. Parra-Rojas et al. [28] detected that homozygous GG carriers showed significantly higher serum triglycerides than GA carriers. Pereira et al. [29] performed a meta-analysis for ischemic stroke, and they showed that the G-308A polymorphism might be a protective factor against ischemic stroke in Asians only.
###end p 27
###begin p 28
###xml 218 227 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
In our study, the GG genotype was higher in PEX glaucoma patients than in healthy controls. In conclusion, we could not find significant association between the 308 G/A genotype and the susceptibility to PEX glaucoma. TNF-alpha-308 G/G may be a genetic marker for identifying patients with increased risk of PEX glaucoma. Exactly how the GG polymorphism works to influence risk for PEX glaucoma remains unknown. Probably the genetic background of our population may be the reason for higher frequency of GG genotype in PEX glaucoma. Further studies are needed to confirm this finding.
###end p 28
###begin title 29
References
###end title 29
###begin article-title 30
Matrix metalloproteinase and tumor necrosis factor in glaucomatous optic nerve head.
###end article-title 30
###begin article-title 31
Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma.
###end article-title 31
###begin article-title 32
Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma.
###end article-title 32
###begin article-title 33
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma.
###end article-title 33
###begin article-title 34
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
###end article-title 34
###begin article-title 35
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cytokine gene nucleotide sequence aligments: supplement 1.
###end article-title 35
###begin article-title 36
###xml 33 38 <span type="species:ncbi:9606">human</span>
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.
###end article-title 36
###begin article-title 37
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Tumour necrosis factor-alpha gene polymorphism (-308 G-A) in Turkish pediatric thrombosis patients.
###end article-title 37
###begin article-title 38
###xml 82 90 <span type="species:ncbi:9606">patients</span>
TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients.
###end article-title 38
###begin article-title 39
Common polymorphism in the tumour necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thromboembolism
###end article-title 39
###begin article-title 40
Analysis of gene diversity in subdivided populations.
###end article-title 40
###begin article-title 41
Accuracy of estimated phylogenetic trees from molecular data. II. Gene frequency data.
###end article-title 41
###begin article-title 42
Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma
###end article-title 42
###begin article-title 43
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
###end article-title 43
###begin article-title 44
###xml 74 82 <span type="species:ncbi:9606">patients</span>
etal. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
###end article-title 44
###begin article-title 45
Association of LOXL1 Gene Polymorphisms with Pseudoexfoliation in the Japanese.
###end article-title 45
###begin article-title 46
The family of matrix metalloproteinases
###end article-title 46
###begin article-title 47
Matrix metalloproteinases
###end article-title 47
###begin article-title 48
###xml 33 38 <span type="species:ncbi:9606">human</span>
Effects of a polymorphism of the human tumour necrosis factor-alpha promoter on transcriptional activation.
###end article-title 48
###begin article-title 49
Association of tumour necrosis factor alpha -308 gene polymorphism with primary open-angle glaucoma in Chinese.
###end article-title 49
###begin article-title 50
TNF-alpha promoter polymorphisms and primary open-angle glaucoma.
###end article-title 50
###begin article-title 51
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma.
###end article-title 51
###begin article-title 52
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyopathy.
###end article-title 52
###begin article-title 53
###xml 58 67 <span type="species:ncbi:10090">nude mice</span>
In vivo effects of cytokines on psoriatic skin grafted on nude mice: involvement of the tumour necrosis factor (TNF) receptor.
###end article-title 53
###begin article-title 54
TNF- alpha gene promoter -238G>A and -308G>A Polymorphisms Alter Risk of Psoriasis Vulgaris: A Meta-Analysis.
###end article-title 54
###begin article-title 55
Role of cytokines in inducing hyperlipidemia.
###end article-title 55
###begin article-title 56
Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects.
###end article-title 56
###begin article-title 57
Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis.
###end article-title 57

